550370-19-9 Usage
Uses
Used in Organic Synthesis:
1,4'-BIPIPERIDIN-4-OL is used as a building block for the synthesis of various heterocyclic compounds, contributing to the development of new organic molecules with potential applications in different industries.
Used in Coordination Chemistry:
1,4'-BIPIPERIDIN-4-OL is used as a ligand, playing a crucial role in the formation of coordination compounds, which have applications in areas such as catalysis, materials science, and medicinal chemistry.
Used in Pharmaceutical and Agrochemical Industries:
1,4'-BIPIPERIDIN-4-OL is used as a starting material for the synthesis of pharmaceuticals and agrochemicals, enabling the development of new drugs and pesticides with improved efficacy and selectivity.
Used in Drug Discovery:
1,4'-BIPIPERIDIN-4-OL is used as a potential enzyme inhibitor, providing a foundation for the discovery of new therapeutic agents targeting specific enzymes involved in various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 550370-19-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,0,3,7 and 0 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 550370-19:
(8*5)+(7*5)+(6*0)+(5*3)+(4*7)+(3*0)+(2*1)+(1*9)=129
129 % 10 = 9
So 550370-19-9 is a valid CAS Registry Number.
550370-19-9Relevant academic research and scientific papers
3-PHENYLSULPHONYL-QUINOLINE DERIVATIVES AS AGENTS FOR TREATING PATHOGENIC BLOOD VESSELS DISORDERS
-
Paragraph 0323, (2021/04/23)
The disclosure provides compounds, and compositions, including pharmaceutical compositions, kits that include the compounds, and methods of using (or administering) and making the compounds. The disclosure further provides compounds or compositions thereof for use in a method of modulating PLXDC1 (TEM7) and/or PLXDC2 or killing pathogenic blood vessles. The disclosure further provides compounds or compositions thereof for use in a method of treating a disease, disorder, or condition that is mediated, at least in part, by PEDF receptors or by angiogenesis.
Chemical compounds
-
, (2008/06/13)
The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) or H1 mediated disease state.
